Registration Details for Immunovia’s Second Webinar in the Series on IMMray™ PanCan-d: Commercial Test Model Study & Update on Launch Activities
LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”), today announced that the company will be hosting the second webinar in the series on Immunovia’s IMMray™ PanCan-d. This second webinar will cover the results of the Commercial Test Model Study (link to pr ) and updates on the launch activities. Event Details: Immunovia’s IMMray™ PanCan-d Webinar Series Webinar No. 2: Commercial Test Model Study &